A pooled SPYRAL HTN analysis (n = 2,137) showed sustained blood pressure reductions through 3 years after Symplicity Spyral renal denervation. A separate pooled analysis found a 42% reduction in ...

Route 92 Medical, Inc. announced the commencement of the SUMMIT RISE postmarket study evaluating the performance of the company&rs ...

VS3 Medical, Inc. announced it has commenced enrollment in an international first-in-human (FIH) study evaluating the VS3 Med ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Salus Scientific Corporation, a developer of radiation protection garments and clinical workflow solutions for fluoroscopy-guided ...

BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...

VentureMed Group, Inc. announced it is now doing business as (DBA) Flex Vascular. The medical device company specializes in ...

A clinical discussion on how the long-term findings of the ZILVERPASS study inform decision-making for challenging ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

We value keeping the Device Guide up to date.

How do we take on and resolve vein-related pelvic pain in women? PeVD has been associated with venous-origin chronic pelvic ...